HOME >> MEDICINE >> NEWS
Mecca pilgrims a priority for meningococcal vaccination

N.B. Please note that if you are outside North America the embargo date for Lancet press material is 0001 hour UK time Friday 15th February 2002.

Muslims travelling to Saudi Arabia for the annual Hajj religious festival are a high priority for enhanced meningococcal vaccination this year. Thirty-three cases and nine fatalities were reported in England and Wales, a similar number to that reported in 2000, despite the recommendation to use a different vaccine in 2001. Better implementation of control policies are needed to prevent an outbreak of meningococcal disease among pilgrims and their contacts this year, conclude authors of a research letter in this weeks issue of THE LANCET.

An outbreak of a previously rare strain (W135) meningococcal disease was seen in 2000 and 2001 among pilgrims returning from Saudi Arabia and their contacts. The Public Health Laboratory Service (covering England and Wales) set up enhanced surveillance to monitor spread and virulence of the outbreak strain, and to collect data on case characteristics. The incidence of disease amongst pilgrims reported from England and Wales in 2001 was similar (28 per 100,000) to the rate reported during 2000 (30 per 100,000), despite a change in the recommendation for pilgrims to receive the quadrivalent vaccine instead of the bivalent vaccine recommended in 2000. Both the recommendation and vaccine were not available until January, 2001, and coverage among pilgrims to the Hajj 2001 was low (below 47%). The casefatality ratio was high (20%), and sustained transmission of the virulent outbreak strain was seen.

Mary Ramsay of the PHLS comments: This outbreak is characterised by a high case-fatality rate that might reflect the virulence of the strain or characteristics of this group of patients. As well as primary prevention, attempts should be made to improve outcome. Preadmission treatment of suspected meningococcal disease in primary care with intravenous benzylpen
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-0-20-7611-4076
Lancet
14-Feb-2002


Page: 1 2

Related medicine news :

1. All Hajj pilgrims should get meningitis jab
2. Child health must become UNICEFs priority over next decade
3. Vaccine development against influenza A (h5n1) virus should be made a priority
4. NPSF makes safe use of pharmaceuticals a national health priority
5. NOVANTRONE application for multiple sclerosis granted priority review by FDA
6. Infectious disease researcher available to discuss new federal recommendations aimed at protecting college students from meningococcal meningitis
7. Many children are undervaccinated or have delayed vaccinations in their first 2 years of life
8. Influenza vaccination programmes for children in USA and Canada based on little evidence
9. Flu vaccination benefits people of any age with high-risk medical conditions
10. Flu vaccination impact on elderly deaths may be over-estimated
11. Risk factors affect parents attitudes about STD vaccinations

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mecca pilgrims priority for meningococcal vaccination

(Date:4/17/2014)... PLOS Pathogens , children who live in regions of ... immune response to infection with malaria parasites that may ... and illness and partially control the growth of malaria ... develop future interventions that prevent or mitigate the disease ... 200 million cases of malaria occur worldwide, resulting in ...
(Date:4/17/2014)... Two recent papers by a University of Colorado ... scientists develop treatments or vaccines for Dengue fever, ... other disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, ... the School of Medicine and an early career ... colleagues recently published articles in the scholarly journals ...
(Date:4/17/2014)... biology team has created a new technology for ... could travel the body and selectively target cancer ... biological devices that monitor and modify human physiology ... However, no existing technology enabled bioengineers to build ... and respond in a customized fashion. , "The ...
(Date:4/17/2014)... estimated that as many as 10 million older Americans ... loneliness and isolation. , However, new research a ... older Americans for six years found that Internet ... depression by more than 30 percent. , "That,s a ... University professor of telecommunication, information studies and media who ...
(Date:4/17/2014)... 17, 2014 By discovering a new mechanism that ... stroke, researchers at UC Irvine and the Salk Institute ... limit or prevent stroke-induced brain damage. , A complex ... of death and primary reason for disability in the ... stroke and lets blood-borne material into the brain, causing ...
Breaking Medicine News(10 mins):Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014 HeartWare ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that it expects revenues for the fourth ... expected full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... N.J. , Jan. 14, 2014 InformEx, ... and sellers of high-value chemistry, will hold the 30 th ... Miami Beach Convention Center from January 21-24. ... 3,500 attendees from top pharmaceutical, fine chemical and specialty chemical ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: